文献速递脑血管病外科神经重症

破裂性深部脑动静脉畸形的管理与结局预测因素

Management and outcome predictors of patients with ruptured deep-seated brain arteriovenous malformations.
PubMed 文献 · J Neurosurg · 2023-08-11

该研究基于1990—2021年单中心数据库,纳入177例破裂性深部脑动静脉畸形患者。治疗前年出血风险为8.24%,治疗后降至1.65%。根治性治疗(手术或放射外科)与随访出血风险降低、畸形团闭塞率提高、不良mRS评分及死亡风险降低相关。

要点

  • 根治性治疗与随访出血风险降低相关(HR 0.267)。
  • 根治性治疗与畸形团闭塞率提高相关(OR 8.864)。
  • 吸烟与死亡风险升高相关(OR 6.068)。

核心结论

  • 根治性治疗策略似乎有助于实现更高的闭塞率和更低的出血率,同时降低不良mRS评分、mRS评分恶化和死亡的风险。
  • 在该类患者中,巢前动脉瘤值得治疗,应鼓励戒烟。

研究设计与样本

  • 研究为基于作者所在机构数据库的回顾性分析,数据跨度为1990—2021年。
  • 数据库中共有1066例脑动静脉畸形患者,最终纳入177例破裂性深部脑动静脉畸形患者。
  • 采用多变量Cox回归和逻辑回归分析分别确定时间事件结局和分类结局的预测因素。

主要发现

  • 治疗前年出血风险为8.24%,治疗后年出血风险降低至1.65%。
  • 巢前动脉瘤与随访出血风险升高相关(HR 2.388,95% CI 1.057-5.398;p=0.036)。
  • 根治性治疗(即手术或放射外科 vs 血管内栓塞或保守管理)与随访出血风险降低相关(HR 0.267,95% CI 0.118-0.602;p=0.001)。
  • Spetzler-Martin IV级和V级(OR 0.404,95% CI 0.171-0.917;p=0.033)及脑干动静脉畸形(OR 0.325,95% CI 0.128-0.778;p=0.014)与闭塞几率降低相关,而根治性治疗与闭塞几率升高相关(OR 8.864,95% CI 3.604-25.399;p=0.008)。
  • 控制基线mRS评分后,小脑动静脉畸形(OR 0.286,95% CI 0.098-0.731;p=0.013)和根治性治疗(OR 0.361,95% CI 0.160-0.807;p=0.013)与不良mRS评分几率降低相关,根治性治疗与mRS评分恶化几率降低相关(OR 0.208,95% CI 0.076-0.553;p=0.001);吸烟与死亡几率升高相关(OR 6.068,95% CI 1.531-25.581;p=0.01),根治性治疗与死亡几率降低相关(OR 0.101,95% CI 0.024-0.361;p=0.007)。

临床怎么用

  • 作者认为,根治性治疗策略似乎有益,可提高闭塞率、降低出血率,并降低不良mRS评分、mRS评分恶化和死亡的几率。
  • 作者建议,在该类患者中,巢前动脉瘤值得治疗,并应鼓励戒烟。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Decision-making for the management of ruptured deep-seated brain arteriovenous malformations (bAVMs) is controversial. This study aimed to shed light on the treatment outcomes of patients with ruptured deep-seated bAVMs. METHODS: Data on bAVM patients were retrieved from the authors' institutional database, spanning 1990-2021. The outcomes were annual hemorrhage risk (before and after intervention), number of follow-up hemorrhages, bAVM obliteration, poor modified Rankin Scale (mRS) score (i.e., mRS score > 2), worsened mRS score, and mortality. Multivariable Cox and logistic regression analyses were conducted to determine predictors of time-to-event and categorical outcomes, respectively. RESULTS: Of the 1066 patients in the database with brain bAVM, 177 patients harboring ruptured deep-seated bAVMs were included. The pretreatment annual hemorrhage risk was 8.24%, and the posttreatment risk was lowered to 1.65%. In multivariable Cox regression analysis, a prenidal aneurysm (HR 2.388, 95% CI 1.057-5.398; p = 0.036) was associated with a higher risk of follow-up hemorrhage, while definitive treatment (i.e., either surgery or radiosurgery vs endovascular embolization or conservative management) (HR 0.267, 95% CI 0.118-0.602; p = 0.001) was associated with a lower risk of follow-up hemorrhage. In multivariable logistic regression analysis, Spetzler-Martin grades IV and V (OR 0.404, 95% CI 0.171-0.917; p = 0.033) and brainstem arteriovenous malformation (AVM) (OR 0.325, 95% CI 0.128-0.778; p = 0.014) were associated with lower odds of obliteration, while definitive treatment (OR 8.864, 95% CI 3.604-25.399; p = 0.008) was associated with higher obliteration odds. Controlling for baseline mRS score, cerebellar AVM (OR 0.286, 95% CI 0.098-0.731; p = 0.013) and definitive treatment (OR 0.361, 95% CI 0.160-0.807; p = 0.013) were associated with lower odds of a poor mRS score, and definitive treatment (OR 0.208, 95% CI 0.076-0.553; p = 0.001) was associated with lower odds of a worsened mRS score. Furthermore, smoking (OR 6.068, 95% CI 1.531-25.581; p = 0.01) and definitive treatment (OR 0.101, 95% CI 0.024-0.361; p = 0.007) were associated with higher and lower mortality odds, respectively. CONCLUSIONS: A definitive treatment strategy seems to be beneficial in achieving higher obliteration and lower hemorrhage rates while decreasing the odds of a poor mRS score, worsened mRS score, and mortality. In this category of patients, prenidal aneurysms warrant treatment, and smoking cessation should be encouraged.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Sattari SA, Yang W, Feghali J, et al. Management and outcome predictors of patients with ruptured deep-seated brain arteriovenous malformations. J Neurosurg. 2023. PMID: 37721414. doi:10.3171/2023.6.JNS23459

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。